financetom
Business
financetom
/
Business
/
GameStop Shares Are Trading Higher: This Week In Review
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GameStop Shares Are Trading Higher: This Week In Review
Sep 2, 2024 3:06 AM

GameStop Corporation ( GME ) shares closed up 8.88% at $23.42 on Friday. Here’s a recap of the key events and developments from this week that contributed to the stock’s movement:

Upcoming Q2 Earnings Report:

GameStop ( GME ) is scheduled to release its second-quarter earnings report on September 10 2024, after the market closes.

Analysts expect an EPS loss of 9 cents and revenue of $895.67 million for the quarter.

Credit Facility Termination:

Earlier this week, GameStop ( GME ) announced the termination of its $250 million credit facility.

This decision indicates a strategic shift towards relying more on cash from operations and cash on hand as the primary sources of liquidity.

Retail Strategy Shift:

GameStop ( GME ) is making efforts to revitalize its retail presence by converting some stores into retro gaming retailers.

This move targets nostalgia-driven gamers interested in older consoles and games, aiming to capitalize on the growing retro gaming market.

Retail Investor Interest:

Despite the recent surge in stock price, the level of retail investor interest did not match the intensity of the 2021 meme stock frenzy.

SEC data shows that retail participation during the stock’s May rally was roughly half of what it was during the original surge.

Year-to-Date Performance:

GameStop’s stock has experienced a 27% increase year-to-date, reflecting a gradual recovery and investor optimism despite the challenges faced by the company.

This combination of upcoming earnings, strategic shifts and evolving retail strategies has driven GameStop's ( GME ) stock performance this week.

See Also:

Gold Falls 1%; MongoDB Shares Spike Higher

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved